Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma and application for diagnosis and treatment
Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma and application for diagnosis and treatment
批准号:
12470049
负责人:
SAKAMOTO Michiie
金额:
$3.65万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
肝内转移是影响肝细胞癌预后的重要因素之一。由rho和p160 rho相关的卷曲卷曲形成蛋白激酶(p160ROCK)信号通路介导的细胞运动最近被证明在人类HCC的肝内转移中起关键作用。其中一种高度转移的细胞系,具有高水平c-Src激酶活性的KYN-2细胞在贴壁状态下变得分散,延伸板足,并表现出高运动性。显性阴性突变型c-Src的表达导致应力纤维的形成和局灶粘连,并显著降低运动性。这表明c-Src激活在癌细胞迁移和转移中起关键作用。为了研究特异性p160ROCK抑制剂Y-27632是否也能抑制肝内转移,我们研究了Y-27632对Li7细胞运动和肝内转移的影响。Y-27632明显阻断肌动蛋白重组,提高溶血磷脂酸介导的Li7细胞的组织和运动能力。Y-27632通过微渗透泵连续注入腹腔,同时将Li7细胞原位植入SCID小鼠肝脏。y -27632治疗组小鼠转移性结节发生率降低。这些发现证实了Rho/p160ROCK信号通路在人肝癌肝内转移中的重要性,提示Y-27632可能对预防人肝癌肝内转移有一定作用。采用差异显示分析方法筛选肝癌转移相关关键基因。一个新的基因,DRH1,在HCC中经常被下调。CO-029在HCC和肝内扩散的肿瘤中频繁且显著过表达。相比之下,其他四跨蛋白CD9和CD82的mRNA表达在HCC中下调,特别是在肝内扩散的肿瘤中。提示CO-029在促进肝癌转移中有一定作用。少
英文摘要
Intrahepatic metastasis is one of the most important prognostic factors for patients with hepatocellular carcinoma (HCC). Cell motility mediated by Rho-and p160 Rho-associated coiled-coil forming protein kinase (p160ROCK) signaling pathways has recently been shown to play a critical role in intrahepatic metastasis in human HCC. One of such highly metastatic cell line, KYN-2 cells having a high level of c-Src kinase activity become scattered, extend lamellipodia, and exhibit high motility in adherent condition. Expression of a dominant-negative mutant form of c-Src caused formation of stress fibers and focal adhesions, and markedly reduced motility. it was suggested that c-Src activation is critically involved in carcinoma cell migration and metastasis. To investigate whether the specific p160ROCK inhibitor Y-27632 could also inhibit intrahepatic metastasis, the effect of Y-27632 on the cell motility and intrahepatic metastasis of Li7 was investigated. Y-27632 markedly blocked actin reo … More rganization and motility of Li7 cells mediated by lysophosphatidic acid. Y-27632 was administered continuously into the peritoneal cavity using a micro-osmotic pump, together with orthotopic implantation of Li7 cells into the liver of SCID mice. The incidence of mice with metastatic nodules decreased in the Y-27632-treated group. These findings confirm the importance of the Rho/p160ROCK signaling pathway in intrahepatic metastasis of human HCC, and indicate that Y-27632 may be useful for the prevention of intrahepatic metastasis of human HCC.Crucial genes involved in liver cancer metastasis were screened using differential display analysis. A novel gene, DRH1, which is frequently down-regulated in HCC was identified. CO-029 was found to be frequently and significantly overexpressed in HCC and in tumors with intrahepatic spreading. In contrast, mRNA expression of the other tetraspanins CD9 and CD82 was down-regulated in HCC, especially in tumors with intrahepatic spreading. It was suggested that CO-029 has some roles in the promotion of metastasis of HCC. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kanetaka K., Sakamoto M., et al.: "Involvement of c-Src in carcinoma cell motility and metastasis."Jpn. J. Cancer Res.. 92(9). 941-946 (2001)
Kanetaka K.、Sakamoto M. 等:“c-Src 在癌细胞运动和转移中的参与”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takamura,M.,Sakamoto,M.,Genda,T.,Ichida,T.,Asakura,H.,Hirohashi,S.: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632."Hepatology. (In press). (2001)
Takamura,M.、Sakamoto,M.、Genda,T.、Ichida,T.、Asakura,H.、Hirohashi,S.:“Rho 相关蛋白激酶抑制剂 Y-27632 抑制人肝细胞癌肝内转移。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kengo Kanetaka, Michiie Sakamoto, Yoshiya Yamamoto, Susumu Yamasaki, Francois Lanza, Takashi Kanematsu, Setsuo Hirohashi: "Overexpression of tetraspanin CO-029 in hepatocellular carcinoma"J. Hepatol.. 35. 637-642 (2001)
Kengo Kanetaka、Michiie Sakamoto、Yoshiya Yamamoto、Susumu Yamasaki、Francois Lanza、Takashi Kanematsu、Setsuo Hirohashi:“肝细胞癌中四跨膜蛋白 CO-029 的过度表达”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamamoto Y., Sakamoto., et al.: "Cloning and characterization of a novel gene, DRHJ, down-regulated in advanced human hepatocellular carcinoma."Clin. Cancer Res.. 7(2). 297-303 (2001)
Yamamoto Y.、Sakamoto. 等人:“新基因 DRHJ 的克隆和表征,该基因在晚期人类肝细胞癌中下调。”Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakamoto M., et al.: "Involvement of c-Src in carcinoma cell motility and metastasis"Jpn. J. Cancer Res.. 92(9). 941-946 (2001)
Sakamoto M.等:“c-Src参与癌细胞运动和转移”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Establishing the molecular pathology-based subclassification of hepatocellular carcinoma.
-
批准号:26293081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.23万
-
财政年份:2014
-
负责人:SAKAMOTO Michiie
-
依托单位:
Expression and functional analyses of G protein-coupled receptor GPR49/LGR5 in human tissues and diseases
-
批准号:21390108
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2009
-
负责人:SAKAMOTO Michiie
-
依托单位:
Development of individualized diagnosis for cancer of digestive organ
-
批准号:17015042
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$42.69万
-
财政年份:2005
-
负责人:SAKAMOTO Michiie
-
依托单位:
Molecular mechanisms of progression and metastasis of hepatocellular carcinoma and their application on diagnosis and therapy.
-
批准号:15390118
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2003
-
负责人:SAKAMOTO Michiie
-
依托单位:
海外基金